Pope Francis Launches Jubilee Year As Rome Braces For Millions Of Pilgrims
Amid security worries, millions of pilgrims are expected to descend on Rome for a Jubilee Year of major Catholic celebrations ...
Republican-American2d
Pope Francis kicks off yearlong Jubilee that will test his stamina, Rome’s patience
VATICAN CITY Pope Francis kicked off the 2025 Holy Year on Tuesday, inaugurating a celebration of the Catholic Church that is ...
interaksyon.philstar2d
Rome completes marquee project in contentious city overhaul for Catholic Holy Year
Vatican expects 32 million tourists for Holy Year Rome overhaul cost estimated at 3.7 billion euros Construction frenzy has ...
‘The Birds’ star Rod Taylor, a Hollywood hellion, enjoyed ‘hard drinking’ and ‘casual romances’: book
Rod Taylor, the Australian movie star who appeared opposite John Wayne, Tippi Hedren, Doris Day, Jane Fonda and Elizabeth Taylor, died in 2015. He was 84.
Pope Francis launches jubilee, bringing pilgrims and grumbling to Rome
Opening the Holy Doors of St. Peter’s Basilica on Christmas Eve, Pope Francis inaugurates a jubilee year expected to draw 32 ...
essanews.com on MSN5d
Rome's iconic Trevi Fountain reopens with visitor limits
After a three-month renovation, the famous Trevi Fountain in Rome is once again impressing tourists. However, there's a catch ...
Trevi Fountain reopens after renovations, capping at 400 visitors at a time
The opening is just in time for the inauguration of the 2025 Jubilee Holy Year that is expected to draw millions of visitors.
Hosted on MSN5d
Rome's Trevi Fountain Reopens After Renovations, Ready for Jubilee Holy Year
Rome's iconic Trevi Fountain, a symbol of the city's grandeur and one of its most famous... The post Rome's Trevi Fountain ...
NBC Los Angeles5d
A Holy Year is about to start in Rome. Here's what you need to know
Bernini’s fountains in Piazza Navona are glistening white again after a monthslong cleaning. A spiffed-up Trevi Fountain ...
ETF Daily News14d
Trevi Therapeutics (NASDAQ:TRVI) Price Target Raised to $7.50
Trevi Therapeutics (NASDAQ:TRVI – Free Report) had its price target lifted by HC Wainwright from $6.00 to $7.50 in a research report sent to investors on Thursday morning, MarketBeat reports.